NPPA issued a notification regarding fixation of retail price of Ofloxacin IP 50 mg + Metronidazole Benzoate IP eq. to Metronidazole 100 mg Suspension' for M/s Hema Laboratories Pvt. Ltd. (Manufacturer) & M/s Aristo Pharmaceuticals Pvt. Ltd. (Marketer)

Jul 18, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on July 16, 2026, issued a notification regarding the fixation of retail price of Ofloxacin IP 50 mg + Metronidazole Benzoate IP eq. to Metronidazole 100 mg Suspension' for M/s Hema Laboratories Pvt. Ltd. (Manufacturer) & M/s Aristo Pharmaceuticals Pvt. Ltd. (Marketer).

The following has been stated:-

•Each 5 ml contains: Ofloxacin IP 50 mg + Metronidazole Benzoate IP eq. to Metronidazole 100 mg Suspension' for M/s Hema Laboratories Pvt. Ltd. (Manufacturer) & M/s Aristo Pharmaceuticals Pvt. Ltd. (Marketer) the retail price is 0.86 Rs.

[Notification No.: 19(5231)/2026/DP/NPPA/Div.III/14658/2026]

 


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT